Register an account to search through 14,000+ stocks! 

Ad

PLXP – PLx Pharma Inc

✔ COMPLIANT

★★☆

Company Profile

PLx Pharma Inc. is a pharmaceutical company. The Company is focused on its PLxGuard drug delivery platform. Its core product includes VAZALORE, available in two doses 325miligram (mg) and 81 mg, is a formulation of aspirin clinically shown to provide platelet inhibition for patients with vascular disease and diabetic patients who may be candidates for aspirin therapy. Its PLxGuard delivery system uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the GI tract. Its product pipeline also includes other oral non-steroidal anti-inflammatory drugs (NSAIDs) using the PLxGuard drug delivery platform, including PL1200 Ibuprofen 200 mg and PL1200 Ibuprofen 400 mg, for pain and inflammation in Phase I clinical stage.
Ad

Business

PASS

PLx Pharma Inc has cleared the Business screen. Its business activity is compliant with the Shariah standard. If you find this result mistaken or questionable, let us know in the comments.

Impure: N/A

Recommendation Rating

1.8

1

2

3

4

5

Analysts’ Price Targets

Mean 21.5

Low: 4

High: 29

Total Analysts: 4

Financials

PASS

The financials pass two standards and fail in one.

FTSE

Debt / Assets
2.34%
Cash / Assets
84.34%
(Cash + AR) / Assets
84.34%

AAOIFI

Debt / Market cap
0.38%
Non-Compliant Assets
0%

DJIM

Debt / 24MC
0.35%
Cash / 24MC
12.71%
AR / 24MC
0%

Fundamentals

Market cap

Assets

Revenue Growth

Div./Share

$163570546
$26616600
-94.62%

✘ FTSE

✔ AAOIFI

✔ DJIM

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses